Standard anti-tuberculosis treatment and hepatotoxicity: do dosing schedules matter?

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

2003 • 816 citations

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis

1996 • 380 citations

Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.

1978 • 377 citations

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial

2004 • 243 citations

Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study.

1996 • 240 citations

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

2000 • 226 citations

Liver injury during antituberculosis treatment: An 11-year study

1996 • 160 citations

Frequency and type of reactions to antituberculosis drugs: Observations in routine treatment

1996 • 155 citations

Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis

2006 • 152 citations

A controlled trial of six months chemotherapy in pulmonary tuberculosis

1981 • 141 citations

A Nested Case–Control Study on Treatment-related Risk Factors for Early Relapse of Tuberculosis

2004 • 131 citations

The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity.

2004 • 122 citations

Incidence of Hepatotoxicity Due to Antitubercular Medicines and Assessment of Risk Factors

2004 • 121 citations

Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore.

2002 • 112 citations

Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study

1980 • 90 citations

A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B

1997 • 87 citations

A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-smear-negative Pulmonary Tuberculosis: Results at 5 Years

1989 • 84 citations

Antituberculosis treatment-induced hepatotoxicity: role of predictive factors

1995 • 79 citations

Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis.

1981 • 74 citations

Inactive Hepatitis B Surface Antigen Carrier State and Hepatotoxicity During Antituberculosis Chemotherapy

2005 • 72 citations

Risk factors for antituberculous chemotherapy‐induced hepatotoxicity in Japanese pediatric patients

2002 • 69 citations

CONTROLLED TRIAL OF FOUR THRICE-WEEKLY REGIMENS AND A DAILY REGIMEN ALL GIVEN FOR 6 MONTHS FOR PULMONARY TUBERCULOSIS

1981 • 40 citations

Risk factors for hepatotoxicity induced by antituberculosis drugs.

1997 • 19 citations